🚀 VC round data is live in beta, check it out!
Labiana Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Labiana Health and similar public comparables like SCYNEXIS, Rein Therapeutics, Xilio Therapeutics, Nicox and more.
Labiana Health Overview
About Labiana Health
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include a GMP manufacturer for EU animal and human health industries, a manufacturer specializing in sterile and lyophilized dosage forms, and a source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol. The company operates in two segment Animal Health and Human Health.
Founded
2017
HQ
Employees
370
Website
Sectors
Financials (LTM)
EV
$87M
Labiana Health Financials
Labiana Health reported last 12-month revenue of $90M and EBITDA of $14M.
In the same LTM period, Labiana Health generated $55M in gross profit, $14M in EBITDA, and $6M in net income.
Revenue (LTM)
Labiana Health P&L
In the most recent fiscal year, Labiana Health reported revenue of $78M and EBITDA of $11M.
Labiana Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $90M | XXX | $78M | XXX | XXX | XXX |
| Gross Profit | $55M | XXX | $48M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $14M | XXX | $11M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $6M | XXX | $299K | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | — | — | $33M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Labiana Health Stock Performance
Labiana Health has current market cap of $49M, and enterprise value of $87M.
Market Cap Evolution
Labiana Health's stock price is $5.80.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $87M | $49M | 2.3% | XXX | XXX | XXX | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLabiana Health Valuation Multiples
Labiana Health trades at 1.0x EV/Revenue multiple, and 6.1x EV/EBITDA.
EV / Revenue (LTM)
Labiana Health Financial Valuation Multiples
As of April 18, 2026, Labiana Health has market cap of $49M and EV of $87M.
Equity research analysts estimate Labiana Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Labiana Health has a P/E ratio of 8.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $49M | XXX | $49M | XXX | XXX | XXX |
| EV (current) | $87M | XXX | $87M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 6.1x | XXX | 8.2x | XXX | XXX | XXX |
| EV/EBIT | 8.1x | XXX | 14.5x | XXX | XXX | XXX |
| EV/Gross Profit | 1.6x | XXX | 1.8x | XXX | XXX | XXX |
| P/E | 8.9x | XXX | 164.8x | XXX | XXX | XXX |
| EV/FCF | 116.6x | XXX | 17.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Labiana Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Labiana Health Margins & Growth Rates
Labiana Health's revenue in the last 12 month grew by 12%.
Labiana Health's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Labiana Health's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Labiana Health's rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Labiana Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 25% | XXX | 24% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 47% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Labiana Health Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Labiana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| SCYNEXIS | XXX | XXX | XXX | XXX | XXX | XXX |
| Rein Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Xilio Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Nicox | XXX | XXX | XXX | XXX | XXX | XXX |
| Cessatech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Labiana Health M&A Activity
Labiana Health acquired XXX companies to date.
Last acquisition by Labiana Health was on XXXXXXXX, XXXXX. Labiana Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Labiana Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLabiana Health Investment Activity
Labiana Health invested in XXX companies to date.
Labiana Health made its latest investment on XXXXXXXX, XXXXX. Labiana Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Labiana Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Labiana Health
| When was Labiana Health founded? | Labiana Health was founded in 2017. |
| Where is Labiana Health headquartered? | Labiana Health is headquartered in Spain. |
| How many employees does Labiana Health have? | As of today, Labiana Health has over 370 employees. |
| Is Labiana Health publicly listed? | Yes, Labiana Health is a public company listed on Bolsa de Madrid. |
| What is the stock symbol of Labiana Health? | Labiana Health trades under LAB ticker. |
| When did Labiana Health go public? | Labiana Health went public in 2022. |
| Who are competitors of Labiana Health? | Labiana Health main competitors are SCYNEXIS, Rein Therapeutics, Xilio Therapeutics, Nicox. |
| What is the current market cap of Labiana Health? | Labiana Health's current market cap is $49M. |
| What is the current revenue of Labiana Health? | Labiana Health's last 12 months revenue is $90M. |
| What is the current revenue growth of Labiana Health? | Labiana Health revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Labiana Health? | Current revenue multiple of Labiana Health is 1.0x. |
| Is Labiana Health profitable? | Yes, Labiana Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Labiana Health? | Labiana Health's last 12 months EBITDA is $14M. |
| What is Labiana Health's EBITDA margin? | Labiana Health's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Labiana Health? | Current EBITDA multiple of Labiana Health is 6.1x. |
| What is the current FCF of Labiana Health? | Labiana Health's last 12 months FCF is $747K. |
| What is Labiana Health's FCF margin? | Labiana Health's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Labiana Health? | Current FCF multiple of Labiana Health is 116.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.